The PSA test for prostate cancer, which IMHO, has been a Full Employment Act for Urologists, as well as a sales brochure for daVinci robotic surgery machines, is no longer recommended for any man.
The task force said it conducted a review of clinical studies of PSA testing, including a large U.S. study and a European one. The U.S. study didn't find a mortality benefit. The task force said the European study suggested a small benefit of no more than 1 in 1,000 men screened.Arguing against this test is like arguing against breast cancer screening. That too, has failed to show any true benefit. What we cannot handle intuitively is the false positive problem. Our "better safe than sorry" mentality should be replaced with "worse likely harmed than rarely sorry". Neither popular screening generates any good for the vast majority as well as much harm for way too many.
"Many men are harmed by prostate-cancer screening" with a PSA test, said Michael LeFevre, the task force's co-chairman and a professor at the University of Missouri School of Medicine. "Very few will benefit." The task force is made up of 16 nonfederal, primary-care providers who review preventative health services and make recommendations, primarily for primary-care doctors.
Dr. LeFevre said the task force recommended doctors could still offer the PSA test if men are informed about the risks and benefits of the test. The blood test is meant to detect a substance found normally in the prostate that is also made by cancer cells. Men with higher PSA scores typically have a higher risk of developing prostate cancer. But the test isn't perfect, and in some cases follow-up biopsies find no cancer. [More]
Just say no, amigos.